Canine red blood cell thiopurine S-methyltransferase: Companion animal pharmacogenetics

Pharmacogenetics

Volumn 12, Issue 9, 2002, Pages 713-724

  Salavaggione, Oreste E ^a   Kidd, Linda ^b   Prondzinski, Janel L ^a   Szumlanski, Carol L ^a   Pankratz, V Shane ^a   Wang, Liewei ^a   Trepanier, Lauren ^b   Weinshilboum, Richard M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Canine gene polymorphism; Pharmacogenetics; Thiopurine S methyltransferase; TPMT

Indexed keywords

THIOPURINE METHYLTRANSFERASE;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CODON; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; INHERITANCE; KINETICS; MALE; MOLECULAR CLONING; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ANIMALS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; DOGS; ERYTHROCYTES; EXONS; GENE FREQUENCY; GENOTYPE; INTRONS; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHARMACOGENETICS; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

ANIMALIA; CANIS; CANIS FAMILIARIS; INSERTION SEQUENCES;

EID: 12244263454     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200212000-00005     Document Type: Article

References (40)

1. Weinshilboum RM. The therapeutic revolution. Clin Pharmacol Ther 1987; 42:481-484.
2. Weinshilboum RM, Otterness DM, Szumlanski CL. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999; 39:19-52.
3. Weinshilboum R. Thiopurine pharmacogenetics: Clinical and molecular studies of thiopurine methyltransferase. Drug Met Dispos 2001; 29:601-605.
4. Remy CN. Ribonucleotides and ribonucleosides as methyl acceptors for S-adenosylmethionine: (Amino- and thio-) purine methyltransferases. Incorporation of 6-amino-2-methylaminopurine into ribonucleic acids. Biochim Biophys Acta 1967; 138:258-275.
5. Woodson LC, Weinshilboum RM. Human kidney thiopurine methyltransferase: Purification and biochemical properties. Biochem Pharmacol 1983; 32:819-826.
6. Paterson ARP, Tidd DM. 6-Thiopurines. In: Sartorelli AC, Johns DG, eds. Antineoplastic and Immunosuppressive Agents II. New York: Springer Verlag; 1975, pp. 384-403.
7. Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992; 43:329-339.
8. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32:651-662.
9. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, et al. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996; 15:17-30.
10. Tai H-L, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, et al. Thiopurine S-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996; 58:694-702.
11. Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987; 41:18-25.
12. Evans WE, Horner M, Chu YQ, Kalwinsky D, Roberts WM. Altered mercaptopurine metabolism, toxic effects and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphoblastic leukemia. J Pediatr 1991; 119:985-989.
13. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 1990; 336:225-229.
14. Mayo Foundation. Thiopurine methyltransferase measurement. Mayo Found Lab Med Bull 1991; 14:1.
15. Rinkardt NE, Kruth SA. Azathioprine-induced bone marrow toxicity in four dogs. Can Vet J 1996; 37:612-613.
16. Beale KM. Azathioprine for treatment of immune-mediated diseases of dogs and cats. J Am Vet Med Assn 1988; 192:1316-1318.
17. Weinshilboum RM, Raymond FA, Pazmiño PA. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85:323-333.
18. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM. Human liver thiopurine methyltransferase pharmacogenetics: Biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 1992; 2:148-159.
19. Frohman MA, Dush MK, Martin GR. Rapid production of full-length cDNAs from rare transcripts: Amplification using single gene-specific oligonucleotide primers. Proc Natl Acad Sci USA 1988; 85:8998-9002.
20. Chadwick RB, Conrad MP, McGinnis MD, Johnston-Dow L, Spurgeon SL, Kronick MN. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. BioTechniques 1996; 20:676-683.
21. Yang F, Graphodatsky AS, O'Brien PCM, Colabella A, Solanky N, Squire M, et al. Reciprocal chromosome painting illuminates the history of genome evolution of the domestic cat, dog and human. Chrom Res 2000; 8:393-404.
22. Kaufman RJ. Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors. Proc Natl Acad Sci USA 1985; 82:689-693.
23. Honchel R, Aksoy I, Szumlanski C, Wood TC, Otterness DM, Wieben ED, et al. Human thiopurine methyltransferase: Molecular cloning and expression of T84 colon carcinoma cell cDNA. Mol Pharmacol 1993; 43:878-887.
24. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucl Acids Res 1997; 25:2745-2751.
25. Gordon D, Abajian C, Green P. Consed: A graphical tool for sequence finishing. Genome Res 1998; 8:195-202.
26. Wilkinson GN. Statistical estimations in enzyme kinetics. Biochem J 1961; 80:324-332.
27. Cleland WW. Computer programs for processing enzyme kinetic data. Nature (Lond) 1963; 198:463-465.
28. Hartl DL, Clark AG. In: Principles of Population Genetics, 3rd Edn. Sunderland, MA: Sinauer Associates, Inc.; 1997. pp. 95-107.
29. Hedrick PW. In: Genetics of Populations, 3rd Edn. Sudbury, MA: Jones and Bartlett Publishers; 2000. pp. 396-405.
30. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995; 56:799-810.
31. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12:921-927.
32. Yan L, Zhang S, Eiff B, Szumlanski CL, Powers M, O'Brien JF, Weinshilboum RM. Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysis. Clin Pharmacol Ther 2000; 68:210-219.
33. White SD, Rosychuk RAW, Outerbridge CA, Fieseler KV, Spier S, Ihrke PJ, Chapman PL. Thiopurine methyltransferase in red blood cells of dogs, cats and horses. Vet Intern Med 2000; 14:499-502.
34. Foster AP, Shaw SE, Duly JA, Shobowale-Bakre EM, Harbour DA. Demonstration of Thiopurine methyltransferase activity in the erythrocytes of cats. J Vet Intern Med 2000; 14:552-554.
35. Vuchetich JP, Weinshilboum RM, Price RA. Segregation analysis of human red blood cell (RBC) thiopurine methyltransferase (TPMT) activity. Genet Epidemiol 1995; 12:1-11.
36. Freimuth RR, Eckloff B, Wieben ED, Weinshilboum RM. Human sulfotransferase SULT1C1 pharmacogenetics: Gene resequencing and functional genomic studies. Pharmacogenetics 2001; 11:747-756.
37. Xu Z-H, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: Gene resequencing, genetic polymorphisms and functional characterization of variant allozymes. Pharmacogenetics 2002; 12:11-21.
38. Thomae BA, Eckloff BW, Freimuth RR, Wieben ED, Weinshilboum RM. Human sulfotransferase SULT2A1 pharmacogenetics: Genotypeto-phenotype studies. Pharmacogenomics J 2002; 2:48-56.
39. Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, et al. Human histamine N-methyltransferase pharmacogenetics: Common genetic polymorphisms that alter activity. Mol Pharmacol 1998; 53:708-717.
40. Shield AJ, Weinshilboum RM. Human catechol O-methyltransferase (COMT) polymorphisms: Functional genomic studies. Drug Metab Reviews 2002; 34:153.